🔎 Trials Near Me

Utama › Kanser (semua jenis) › Minnesota › Minneapolis

Kajian klinikal Kanser (semua jenis) di Minneapolis, MN

22 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi dalam dan sekitar Minneapolis (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

Mengambil pesertaFasa 2
  • University Of Minnesota /ID# 277850, Minneapolis
Umur 18 ke atas · Wanita · Dikemas kini 1 Okt 2026 · NCT07024784

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

Mengambil pesertaFasa 3
  • Metro Minnesota Community Oncology Research Consortium (MMCORC), Saint Louis Park · 5 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06901531

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Mengambil pesertaFasa 2/3
  • M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
Semua umur · Semua jantina · Dikemas kini 18 Sep 2026 · NCT03435796

Connect for Cancer Prevention Study (Connect)

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • HealthPartners, Minneapolis
Umur 30 hingga 70 · Semua jantina · Dikemas kini 17 Sep 2026 · NCT04609072

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581

Project: Every Child for Younger Patients With Cancer

Mengambil pesertaKajian pemerhatian
  • Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
  • University of Minnesota/Masonic Cancer Center, Minneapolis
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT02402244

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • M Health Fairview University of Minnesota Medical Center, Minneapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05919264

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

Mengambil pesertaFasa 2
  • University of Minnesota Hospital, Minneapolis
Umur 1 hingga 39 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT05999994

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Mengambil pesertaFasa 3
  • Abbott-Northwestern Hospital, Minneapolis
  • Hennepin County Medical Center, Minneapolis
  • Health Partners Inc, Minneapolis
  • dan 2 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06580314

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Mengambil pesertaFasa 2
  • 518, Minneapolis
Umur 18 ke atas · Wanita · Dikemas kini 16 Jul 2026 · NCT06906341

Capturing Food Intake in Patients Undergoing Radiation Therapy for Cancer

Mengambil peserta
  • University Of Minnesota, Minneapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Jul 2026 · NCT07682714

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Mengambil pesertaKajian pemerhatian
  • VPCI Oncology Research, Minneapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jul 2026 · NCT05181826

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

Mengambil pesertaFasa 1
  • GSK Investigational Site, Minneapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Jun 2026 · NCT06431594

Childhood Cancer Survivor Study

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Children's Hospitals & Clinics of Minnesota, Minneapolis
Semua umur · Semua jantina · Dikemas kini 17 Jun 2026 · NCT01120353

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Mengambil pesertaFasa 1/2
  • Children's Hospital and Clinics of Minn, Minneapolis
12 Months – 30 Years · Semua jantina · Dikemas kini 19 Mei 2026 · NCT04901702

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Mengambil pesertaFasa 2
  • University of Minnesota, Minneapolis
  • Metro Minnesota Community Oncology Research Consortium, Hennepin County Medical Center, Saint Louis Park · 5 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT01042379

Axelopran for Advanced Cancer in Patients Receiving Opioids

Mengambil pesertaFasa 2
  • HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park · 5 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mei 2026 · NCT07354919

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Mengambil peserta
  • Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Feb 2026 · NCT02984761

Beat Childhood Cancer Specimen Banking and Data Registry

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Children's Hospital and Clinics of Minnesota, Minneapolis
Semua umur · Semua jantina · Dikemas kini 3 Feb 2026 · NCT04715178

Cannabis Use Registry to Improve Overall Understanding of Symptoms (CURIOUS)

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • HealthPartners Institute Cancer Research Center, Saint Louis Park · 5 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Nov 2025 · NCT07227324

Kajian Kanser (semua jenis) di bandar lain

Kajian lain di Minneapolis

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.